Sight Sciences’ management is scheduled to present on Tuesday, April 8, 2025, at 12:45 pm PT / 3:45 pm ET. Interested parties may access a live and archived webcast of the fireside chat on the ...

Patients reported that Miebo significantly reduced overall symptoms severity at the primary endpoint of change from baseline ...

Cataracts are the leading cause of blindness in adults older than age 50 worldwide.The global prevalence of cataracts has ...

Victory Capital Management Inc. purchased a new stake in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) ...

Many of us are dry eye sufferers, especially in the cooler months, but not everyone has to live with red-eyed irritation. We ...

AZR-MD-001, met its primary endpoints of showing improvements in both the signs and symptoms of dry eye disease caused by Meibomian gland dysfunction (MGD) reaching statistical significance ...

NOV03 is being reviewed as a treatment for the signs and symptoms of dry eye disease associated with Meibomian gland dysfunction (MGD), a group which is estimated to account for the majority ...

IgG4-related disease is an increasingly recognized fibroinflammatory condition with protean manifestations. The disorder is ...

The Company’s TearCare ® System is 510(k) cleared in the United States for the application of localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland ...

Food, then, became a convenient way to communicate the appearance of the body – in health and in sickness. This practice is known as eponymophilia and it continues today, particularly in pathology – ...